Competitive Market Share Analysis In The Skin Booster Market

Report Overview

The global skin booster market is experiencing rapid growth, driven by rising consumer interest in skin rejuvenation over volume enhancement. Unlike traditional dermal fillers, skin boosters focus on hydrating and revitalizing the skin, a trend gaining popularity among younger consumers, men, and those seeking subtle anti-aging solutions. Key brands such as Profhilo, Rejuran, and SkinVive by Juvéderm are redefining treatment paradigms across North America, Europe, and Asia-Pacific. 

The competitive analysis report, compiled by Grand View Research, is a collection of the trends and competitive scenario in 5 regions. Qualitative information regarding the trends, competitive strategies, existing competition, and pricing analysis will be provided in the report. Within the purview of the database, such information is systematically analyzed and provided in the form of outlook reports and summary presentations on individual areas of research. 

Skin Booster Market: Competitive Market Share Analysis Report Scope

Skin Boosters Market: Trends and Competitive Analysis Coverage Snapshot 

The skin booster market is undergoing a transformative phase, driven by evolving consumer preferences, clinical advancements, and aggressive expansion strategies from leading players. Unlike traditional dermal fillers that focus on volume restoration, skin boosters prioritize hydration, elasticity, and natural rejuvenation attributes that both consumers and clinicians increasingly favor. The most significant contributor to this growth is the rising popularity of hyaluronic acid (HA)-based boosters such as SkinVive by AbbVie and Profhilo by IBSA, which accounted for a significant share of the market in 2024. These products are widely used across North America, Europe, and Asia Pacific, with strong adoption in medspas and dermatology clinics. Notably, newer ingredients like exosomes and polynucleotides (PDRN/PN) are gaining traction due to their regenerative properties and collagen-stimulating capabilities. Brand penetration is particularly strong in Asia Pacific, where companies like PharmaResearch (Rejuran) and Dexlevo (Gouri) have achieved notable success by catering to local preferences for subtle, natural-looking enhancements. Additionally, Korean products such as Rejuran and Gouri are now expanding into India, Southeast Asia, and parts of Europe. rom a competitive standpoint, Galderma and AbbVie (Allergan) dominate the market. However, newer entrants and regionally strong players like PharmaResearch Co., Ltd. and IBSA Farmaceutici Italia Srl are eroding this dominance through product innovation and geographic expansion. Strategic initiatives have played a critical role in shaping the competitive landscape. For instance, AbbVie’s FDA approval and U.S. launch of SkinVive marked the first officially recognized HA-based skin booster in the country, setting a regulatory precedent and boosting consumer confidence. Meanwhile, companies such as Dexlevo (with Gouri) and Sinclair Pharma have invested in novel formulations like PCL-based injectables and collagen stimulators to differentiate their offerings.

Pricing Analysis

Product Distributor Price

Note: The prices listed above represent an average distributor price, gathered through primary interviews and supplemented by a few secondary sources. 

Pricing within the skin booster market varies significantly based on ingredient type, geographic region, delivery setting, and physician expertise. The most widely used category hyaluronic acid (HA)-based skin boosters-is priced in the mid-to-premium segment. Advanced formulations such as poly-L-lactic acid (PLLA) or poly-D,L-lactic acid (PDLLA) boosters command higher prices due to their collagen-stimulating and long-lasting effects. Exosome-based skin boosters, representing the most cutting-edge segment, are priced at a significant premium because of their perceived regenerative benefits and novel delivery systems. Microneedling-based booster sessions, often combined with HA or PDRN/PN formulations, are generally more affordable and widely adopted.